ADMA Biologics ADMA Convertible Preferred Stock Outstanding Shares
Convertible Preferred Stock Outstanding Shares at other companies
Other financials
Where this comes from
Reported directly by ADMA Biologics in its filing.
Tagged under the XBRL concept us-gaap:PreferredStockSharesOutstanding.
The official record: ADMA Biologics’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about ADMA Biologics's convertible preferred stock outstanding shares.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is ADMA Biologics's convertible preferred stock outstanding shares?
- ADMA Biologics (ADMA) reported convertible preferred stock outstanding shares of 0 in Q1 2026.
- What does convertible preferred stock outstanding shares mean?
- This represents the total number of preferred equity shares that carry the right to be converted into common stock at a predetermined ratio. It serves as a key indicator of potential future dilution for common shareholders. Investors monitor this to evaluate the impact of capital structure complexity on earnings per share.